This just in!🗞️ The NLA was featured in The Washington Post article, “There’s another risk to your heart that’s getting new attention,” highlighting the importance of Lp(a) testing. We’re proud to be part of this critical conversation and remain committed to leading the way in

#NLAFall is your last chance to attend our three CME courses in 2025‼️ Whether you’re just beginning your lipidology journey or ready to elevate your expertise, join us this October in Scottsdale for 3️⃣ dynamic courses. 👉 Learn more & register: lipid.org/fall

Congratulations to our CVRC Director, Michael Widlansky on the recent announcement that he will serve as interim chief of the division of cardiovascular medicine effective Oct. 16 Medical College of Wisconsin

🚨 Our parent-of-origin study is out in nature ! 🧬 Maternal and paternal alleles can have distinct — even opposite — effects on human traits, revealing a hidden layer of genetic architecture that standard GWAS miss. 🔗nature.com/articles/s4158… Highlights below!

A father reviews a 4-month old baby and has an interesting perspective

🔬#ScienceSpotlight: This study is the first to demonstrate neuropathic signs and symptoms, small nerve fiber damage, and cardiac autonomic dysfunction in participants with FCS. @lipidjournal 📖Read the full article: ow.ly/Izw750WCOeM #Research #ScientificResearch #FCS

A new chapter! Honored & excited to start Sep 1 Medical College of Wisconsin of Wisconsin; Div of CV Medicine, CV Research Center & the Mellowes Center for Genomic Sciences & Precision Medicine Looking forward to help implement genomic medicine in clinical care tinyurl.com/yptvssuj

Becoming a Fellow of the NLA (FNLA) is more than an honor — it’s recognition as a true leader in advancing lipid science and patient care.🌟 ➡️Swipe to see the exclusive perks of fellowship. Nominate a colleague today: lipid.org/fellows #Lipidology #MedicalLeadership

Join our American College of Cardiology #Prevention Council & renowned experts for a practical review of the new #Hypertension guidelines @ 1pm on 9/17. Eugene Yang Dr. Joseph Ebinger Leslie davis Eileen Handberg Dr. Keith Ferdinand American Heart Association National Lipid Association ASPC

The primary safety concern for anti-IL-6 therapies is infection risk. In previous work, we have shown that genetically proxied IL6R inhibition increases risk of bacterial infections, consistent with clinical experience with tocilizumab.

National Cholesterol Education Month is officially here!🙌 We’re kicking off LDL-C Week with a roundup of the NLA’s best resources — from FREE CME to #NLASessions talks and more. Explore them all at: ow.ly/RzJQ50WNELQ Which resource are you diving into first?👇

As Science put it: pathogenicity and penetrance are “two sides of the same coin.” ML penetrance brings the clinical spectrum into the equation — complementing lab predictions like AlphaMissense ⚖️ Check out the full perspective by Amelie Stein 👉 doi.org/10.1126/scienc…

Join us at the #2025 #Fredrickson Lipid Research Conference September 3-5, 2025 Medical College of Wisconsin MCWcardiology Versiti Blood Center of Wisconsin Co-Chairs: Ze Zheng mary sorci-thomas

Building on the legacy of many, I'm incredibly excited that we have successfully translated our polygenic risk scores into a validated clinical assay Mass General Brigham Broad Institute, orderable by any clinician in the US today. 🧬To order: massgeneralbrigham.org/en/research-an… 🧬Announcement:

Congratulations 🎊 to Iftikhar J. Kullo on his appointment as an Associate Director for the Center for #Genomic Sciences and #Precision Medicine MCW Mellowes Center 🍀 ! Michael Widlansky Eric Green MCWcardiology

Outstanding talk on genomics and AI by ⁦Iftikhar J. Kullo⁩ ⁦WisconsinACC⁩

Congratulations to Leili Behrooz !🎊🌟 Navigating strong the #CVprevention and #LEPAD word American College of Cardiology WisconsinACC

A great opportunity for junior faculty! MCW Mellowes Center MCWcardiology Maya S Safarova, MD, PhD